Clinical Trials Browser

Phase 2 × Not yet recruiting × Neurofibrosarcoma × Clear all

NCT05253131 2026-02-11

Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas

Phase 2 Not yet recruiting

Neurofibromatosis 1, Sarcoma, Neurofibrosarcoma